Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Life sciences-focused search firm Slone Partners has recruited Jeremy Bender, Teresa Bitetti, and David Meek as members of the board of directors at Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. “Jeremy Bender, Teresa Bitetti, and David Meek are all very accomplished and highly respected leaders in the fields of biopharmaceuticals, oncology,
Life sciences-focused search firm Slone Partners has placed Christophe Arbet-Engels as chief medical officer at X4 Pharmaceuticals Inc., a public biopharmaceutical company. The enterprise is developing novel small molecule therapeutics to benefit patients with diseases of the immune system. Dr. Arbet-Engels previously served as CMO at several life science companies, including Neurogastrx, Millendo Therapeutics, and Poxel Pharmaceuticals,
Until recent years, executive recruiters would often speak about sourcing candidates who seem to be a good “culture fit” for an organization. The idea behind it was that potential hires who were aligned with the look and feel of the existing culture would easily assimilate into it, and would require less time to ramp up
Life sciences-focused search firm Slone Partners has expanded with the addition of Kate Portland as vice president of client partnerships. “Kate Portland is an accomplished and highly respected executive talent recruiter and client development specialist with an impressive track record of success over more than 20 years,” said Leslie Loveless, CEO. “With her vast experience formulating and executing high-level
SOUTH RIDING VA. – July 11, 2023 – Slone Partners, one of the nation’s leading life sciences and healthcare executive search firms, recently announced the appointment of Mike Mosunic as president of Slone Partners Cybersecurity, its subsidiary that delivers leaders for innovative private equity (PE)-backed and venture capital (VC) companies in the cybersecurity industry. Mosunic is an
SOUTH RIDING, VA. – May 18, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Bret Christensen as President, Chief Executive Officer (CEO), and member of the Board of Directors at DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform. Christensen comes to DermTech
SOUTH RIDING, VA. – March 15, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of John Russell as Executive Chairman at Ultromics, a global pioneering health technology company focused on reducing the global burden of heart failure. Russell is a well-respected leader in the medical device and diagnostic sectors
SOUTH RIDING, VA. – March 14, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul Scagnetti as Chief Executive Officer (CEO) at ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform. As CEO, Scagnetti will be
Expanded line reflects Slone Partners’ focus on delivering the most diverse and qualified Board members for amazing organizations SOUTH RIDING, VA. – March 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences and healthcare companies, has announced that it will expand its line of executive Board placement services to serve more companies in life
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025